Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations [Urologic Oncology]

Conclusion
High BMI is a prognostic factor for improved survival and progression-free survival in patients with metastatic RCC treated with targeted therapy. Underlying biology suggests a role for the FASN pathway.

Source: Journal of Clinical Oncology - October 11, 2016 Category: Cancer & Oncology Authors: Albiges, Hakimi, Xie, McKay, Simantov, Lin, Lee, Rini, Srinivas, Bjarnason, Ernst, Wood, Vaishamayan, Rha, Agarwal, Yuasa, Pal, Bamias, Zabor, Skanderup, Furberg, Fay, de Velasco, Preston, Wilson, Cho, McDermott, Signoretti, Heng, Choueiri Tags: Behavioral and Lifestyle Risk Factors, Chemotherapy, Epidemiology, Translational Oncology, Genitourinary Urologic Oncology Source Type: research